Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 10

1.

Major Histocompatibility Complex and Malaria: Focus on Plasmodium vivax Infection.

Lima-Junior Jda C, Pratt-Riccio LR.

Front Immunol. 2016 Jan 27;7:13. doi: 10.3389/fimmu.2016.00013. eCollection 2016. Review.

2.

In silico Identification and Validation of a Linear and Naturally Immunogenic B-Cell Epitope of the Plasmodium vivax Malaria Vaccine Candidate Merozoite Surface Protein-9.

Rodrigues-da-Silva RN, Martins da Silva JH, Singh B, Jiang J, Meyer EV, Santos F, Banic DM, Moreno A, Galinski MR, Oliveira-Ferreira J, Lima-Junior Jda C.

PLoS One. 2016 Jan 20;11(1):e0146951. doi: 10.1371/journal.pone.0146951. eCollection 2016.

3.

Experimental Validation of Multi-Epitope Peptides Including Promising MHC Class I- and II-Restricted Epitopes of Four Known Leishmania infantum Proteins.

Agallou M, Athanasiou E, Koutsoni O, Dotsika E, Karagouni E.

Front Immunol. 2014 Jun 10;5:268. doi: 10.3389/fimmu.2014.00268. eCollection 2014.

4.

Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.

Stanisic DI, Javati S, Kiniboro B, Lin E, Jiang J, Singh B, Meyer EV, Siba P, Koepfli C, Felger I, Galinski MR, Mueller I.

PLoS Negl Trop Dis. 2013 Nov 14;7(11):e2498. doi: 10.1371/journal.pntd.0002498. eCollection 2013 Nov.

5.

The evolution and diversity of a low complexity vaccine candidate, merozoite surface protein 9 (MSP-9), in Plasmodium vivax and closely related species.

Chenet SM, Pacheco MA, Bacon DJ, Collins WE, Barnwell JW, Escalante AA.

Infect Genet Evol. 2013 Dec;20:239-48. doi: 10.1016/j.meegid.2013.09.011. Epub 2013 Sep 14.

6.

Bioinformatic and empirical analysis of novel hypoxia-inducible targets of the human antituberculosis T cell response.

Gideon HP, Wilkinson KA, Rustad TR, Oni T, Guio H, Sherman DR, Vordermeier HM, Robertson BD, Young DB, Wilkinson RJ.

J Immunol. 2012 Dec 15;189(12):5867-76. doi: 10.4049/jimmunol.1202281. Epub 2012 Nov 19.

7.

Influence of HLA-DRB1 and HLA-DQB1 alleles on IgG antibody response to the P. vivax MSP-1, MSP-3α and MSP-9 in individuals from Brazilian endemic area.

Lima-Junior JC, Rodrigues-da-Silva RN, Banic DM, Jiang J, Singh B, Fabrício-Silva GM, Porto LC, Meyer EV, Moreno A, Rodrigues MM, Barnwell JW, Galinski MR, de Oliveira-Ferreira J.

PLoS One. 2012;7(5):e36419. doi: 10.1371/journal.pone.0036419. Epub 2012 May 23.

8.

Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.

Nakayasu ES, Sobreira TJ, Torres R Jr, Ganiko L, Oliveira PS, Marques AF, Almeida IC.

J Proteome Res. 2012 Jan 1;11(1):237-46. doi: 10.1021/pr200806s. Epub 2011 Dec 8.

9.

B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.

Lima-Junior JC, Jiang J, Rodrigues-da-Silva RN, Banic DM, Tran TM, Ribeiro RY, Meyer VS, De-Simone SG, Santos F, Moreno A, Barnwell JW, Galinski MR, Oliveira-Ferreira J.

Vaccine. 2011 Feb 17;29(9):1801-11. doi: 10.1016/j.vaccine.2010.12.099. Epub 2011 Jan 6.

10.

MultiRTA: a simple yet reliable method for predicting peptide binding affinities for multiple class II MHC allotypes.

Bordner AJ, Mittelmann HD.

BMC Bioinformatics. 2010 Sep 24;11:482. doi: 10.1186/1471-2105-11-482.

Items per page

Supplemental Content

Write to the Help Desk